In vivo biodistribution studiesfor [68Ga]Ga-3 showed dual targeting for PSMA(+)and GRPR(+) tumors and higher tumor uptake, faster pharmacokinetic,and lower kidney uptake compared to 1 and 2. Here, FOLH1 is linked to neoplasm.